Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study
A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of The Lancet.
Leave a Response
You must be logged in to post a comment.
